Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Neonatal care

Most preterm neonates receive antibiotics despite concerns over risk and benefits

Research published in JAMA Network Open has shown that antibiotic therapy begins in most preterm neonates within the first three days of life.

Preterm baby in incubator


Researchers found that 78.6% of very low-birthweight babies and 87.0% of extremely low-birthweight babies began antibiotic therapy in the first three days of life

Most preterm neonates receive early antibiotic therapy despite evidence that this can be unnecessary and sometimes harmful, the results of a US study show[1].

The research team used data from 297 hospitals across the United States between 2009–2015, looking at 40,364 very low-birthweight babies (VLBW), including 12,947 extremely low-birthweight infants (ELBW), who survived for at least one day.

They found that, overall, 78.6% of VLBW and 87.0% of ELBW began antibiotic therapy in the first three days of life. Exposure rates varied across centres and there was no significant trend in early prescribing rates detected over the seven-year study period.

Antibiotics are frequently prescribed to preterm neonates because they have an increased risk of sepsis. However, research has shown that in those without confirmed bacterial infection, the risks may outweigh the benefits.

“These findings suggest a continued need for neonatal antibiotic stewardship efforts designed to help clinicians identify premature infants at lowest risk of [early-onset sepsis] to avoid non-indicated, and perhaps harmful, antibiotic exposure,” the team concluded in JAMA Network Open (25 May 2018).

Citation: Clinical Pharmacist DOI: 10.1211/CP.2018.20205131

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Preterm baby in incubator

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.